Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-05-19 @ 5:59 PM
Study NCT ID:
NCT05178134
Status:
COMPLETED
Last Update Posted:
2025-08-19
First Post:
2021-12-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Sponsor:
Scandinavian Biopharma AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OEV-125
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None